NCT04082507 is a clinical trial of Serum alpha-fetoproteine in Placenta Accreta, sponsored by rasha medhat abdul-hady.

Who is sponsoring NCT04082507?

NCT04082507 is sponsored by rasha medhat abdul-hady.

What drugs are being tested in NCT04082507?

Interventions in NCT04082507: Serum alpha-fetoproteine.

What condition does NCT04082507 study?

NCT04082507 studies Placenta Accreta.

Is NCT04082507 still recruiting?

NCT04082507 is currently status unknown. Last updated 9 September 2019.

Last reviewed 2019-09-09 · How we verify

NCT04082507

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

Status unknown Last updated 9 September 2019

What this trial tests

trial testing Serum alpha-fetoproteine in Placenta Accreta in 150 participants. Status unknown.

Timeline

1 January 2017

Primary endpoint
30 August 2019

30 August 2019

Quick facts

Lead sponsor	rasha medhat abdul-hady
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 January 2017
Primary completion	30 August 2019
Estimated completion	30 August 2019
Sites	1 location across Egypt

Drugs / interventions tested

Serum alpha-fetoproteine

Conditions studied

Placenta Accreta — all drugs for Placenta Accreta →

Sponsor

rasha medhat abdul-hady

Who can join

Adults 20 to 39, female only, with Placenta Accreta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Placenta Accreta

Currently open trials in the same condition.

NCT07283042 — Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum · recruiting
NCT06465836 — Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University · NA · recruiting
NCT06185894 — Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery · NA · recruiting
NCT06833606 — Diagnosis and Outcomes of Placental Accretism · recruiting
NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04082507 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by rasha medhat abdul-hady
Last refreshed: 9 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04082507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing